Echo Reference › Mitral Regurgitation
Echo Reference — Valve Regurgitation
Mitral Regurgitation
Qualitative and quantitative severity grading with 4-grade thresholds for primary and secondary MR. ASE integration algorithm, Carpentier functional classification, and EROA/RVol calculator by PISA method.
Qualitative Parameters
| Parameter | Mild | Moderate | Severe |
|---|---|---|---|
| Colour jet area | Small, central, thin | Intermediate | Large central jet (> 40% LA area) or wall-hugging jet of any size |
| Vena contracta width (mm) | < 3 | 3 – 6.9 | ≥ 7 |
| CW Doppler signal | Faint, incomplete envelope | Dense, partial envelope | Dense, triangular (early peaking), complete envelope |
| Mitral inflow | A-dominant or normal | Variable | E-dominant (E > 1.2 m/s) |
| Pulmonary vein flow | S-dominant | S-blunted | Systolic reversal |
Quantitative Parameters — Primary MR
| Parameter | Mild | Moderate | Moderate–Severe | Severe |
|---|---|---|---|---|
| EROA (cm²) | < 0.20 | 0.20 – 0.29 | 0.30 – 0.39 | ≥ 0.40 |
| RVol (mL/beat) | < 30 | 30 – 44 | 45 – 59 | ≥ 60 |
| Regurgitant fraction (%) | < 30 | 30 – 39 | 40 – 49 | ≥ 50 |
Quantitative Parameters — Secondary MR
Secondary (functional) MR has lower thresholds for "severe" classification based on outcome data showing adverse prognosis at lower regurgitant volumes. The COAPT trial used EROA ≥ 0.30 cm² as entry criterion for edge-to-edge repair in secondary MR.
| Parameter | Mild | Moderate | Severe |
|---|---|---|---|
| EROA (cm²) | < 0.20 | 0.20 – 0.29 | ≥ 0.30 |
| RVol (mL/beat) | < 30 | 30 – 44 | ≥ 45 |
Carpentier Functional Classification
| Type | Leaflet Motion | Mechanism | Examples |
|---|---|---|---|
| Type I | Normal | Annular dilatation or leaflet perforation with normal coaptation geometry | AF-related annular dilatation, endocarditis (perforation) |
| Type II | Excessive | Leaflet prolapse or flail — coaptation point displaced into LA | Myxomatous degeneration, chordal rupture, papillary muscle rupture |
| Type IIIa | Restricted (systole + diastole) | Organic leaflet disease with thickening, calcification, and chordal shortening | Rheumatic heart disease, radiation, drug-induced (ergot, anorectic agents) |
| Type IIIb | Restricted (systole only) | Papillary muscle displacement from LV remodelling — leaflets tethered apically | Ischaemic MR (regional wall motion abnormality), dilated cardiomyopathy (global tethering) |
Integration Algorithm — Chronic MR
The ASE recommends a stepwise integration of qualitative and quantitative parameters. When parameters are concordant, grading is straightforward. When discordant, re-examine measurement technique and consider which parameters are most reliable in the given clinical context.
| Step | Action |
|---|---|
| 1. Screen | Colour Doppler jet area and CW signal density. If small central jet with faint signal → likely mild, may not need further quantification. |
| 2. Semi-quantify | Measure vena contracta width. VC < 3 mm → mild. VC ≥ 7 mm → severe. VC 3–6.9 mm → proceed to quantitative methods. |
| 3. Quantify | PISA method for EROA and RVol. Volumetric method (mitral vs aortic SV comparison) as a cross-check. Apply primary or secondary thresholds based on mechanism. |
| 4. Supportive signs | Pulmonary vein flow (systolic reversal → severe), mitral inflow E velocity (> 1.2 m/s → volume-loaded), LV and LA size (dilated in chronic severe MR), PASP (elevated with haemodynamic consequence). |
| 5. Integrate | If ≥ 3 parameters concordant → assign grade. If discordant → reassess technique, consider repeat measurements, and weigh the most reliable parameter for the clinical scenario. |
EROA / RVol Calculator — PISA Method
EROA & RVol by PISA
EROA = (2π × r² × Valiasing) ÷ Vmax MR. Enter the PISA radius (at the aliasing boundary), aliasing velocity, and peak MR CW velocity. MR VTI is optional for RVol calculation.
Clinical Context
PISA Pitfalls
| Pitfall | Impact |
|---|---|
| Non-hemispheric PISA shape | The PISA formula assumes a hemispheric convergence zone. Eccentric jets, wall-hugging jets, and jets near the commissures produce non-hemispheric flow convergence — EROA is underestimated. Apply an angle correction factor when the convergence zone is constrained. |
| Incorrect aliasing velocity | Aliasing velocity should typically be set to 30–40 cm/s for a well-defined PISA hemisphere. Too high → small radius → underestimates EROA. Too low → unmeasurably large radius. |
| Measuring PISA radius at wrong time | Measure in mid-systole when the PISA shell is most hemispheric and stable. Early or late systolic measurements may not represent the true effective orifice. |
| Dynamic MR orifice | In secondary MR, the regurgitant orifice changes throughout systole (often larger in mid-to-late systole). A single mid-systolic PISA measurement may not capture the full regurgitant burden. Consider 3D vena contracta area as a complementary measure. |
| Multiple jets | PISA measures one jet at a time. With multiple MR jets (e.g. bileaflet prolapse), each jet should be assessed separately or the total severity estimated using volumetric methods. |
Acute vs Chronic MR
Acute severe MR (chordal rupture, papillary muscle rupture, endocarditis) presents differently from chronic MR. The LA is non-dilated (no time for remodelling), so even moderate regurgitant volumes produce marked elevation of LA pressure. The CW MR signal is often truncated (early peak, V-wave cutoff) rather than the dense holosystolic signal of chronic severe MR. Colour jet area may be misleadingly small because the high LA pressure reduces the driving gradient. Supportive signs — pulmonary oedema, pulmonary vein systolic reversal, hyperdynamic LV — are critical for recognising acute severe MR.
3D Vena Contracta Area
3D colour Doppler vena contracta area (VCA) is increasingly used as a complement to PISA, particularly for eccentric or non-circular orifices. VCA ≥ 0.40 cm² suggests severe primary MR, analogous to EROA ≥ 0.40. VCA has the advantage of measuring the actual orifice geometry rather than assuming a circular shape. It is less dependent on haemodynamic conditions than PISA but requires adequate 3D image quality.
References
- Zoghbi WA, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):303–371.
- Otto CM, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2021;143(5):e72–e227.
- Vahanian A, et al. 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease. Eur Heart J. 2022;43(7):561–632.
- Stone GW, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure (COAPT). N Engl J Med. 2018;379(24):2307–2318.